Bibliography
- CAULFIELD MP, BIRDSALL NJ: International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. (1998) 50(2):279-290.
- CHAPPLE CR: Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder. Expert Opin. Investig. Drugs. (2004) 13(11):1493-1500
- PAYNE CK: Solifenacin in overactive bladder syndrome. Drugs (2006) 66(2):175-190
- FRYER AD, JACOBY DB: Muscarinic receptors and control of airway smooth muscle. Am. J. Respir. Crit. Care Med. (1998) 158(5Pt3):S154-S160.
- ALABASTER VA: Discovery and development of selective M3 antagonists for clinical use. Life Sci. (1997) 60(13,14):1053-1060.
- KOUMIS T, SAMUEL S: Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin. Ther. (2005) 27(4):377-392.
- NORMAN P: Long acting muscarinic M3 receptor antagonists 2 Theravance. Expert Opin. Ther. Patents (2006) 16(9)::1321-1326.
Patents
- GLAXO GROUP LTD: WO2004012684 (2004).
- GLAXO GROUP LTD: WO2004091482 (2004).
- GLAXO GROUP LTD: WO2005009362 (2005).
- GLAXO GROUP LTD: WO2005009439 (2005).
- GLAXO GROUP LTD: WO2005009440 (2005).
- GLAXO GROUP LTD: WO2005037224 (2005).
- GLAXO GROUP LTD: WO2005037280 (2005).
- GLAXO GROUP LTD: WO2005046586 (2005).
- GLAXO GROUP LTD: WO2005055940 (2005).
- GLAXO GROUP LTD: WO2005055941 (2005).
- GLAXO GROUP LTD: WO2005067537 (2005).
- GLAXO GROUP LTD: WO2005094251 (2005).
- GLAXO GROUP LTD: WO2005095407 (2005).
- GLAXO GROUP LTD: WO2005094834 (2005).
- GLAXO GROUP LTD: WO2005094835 (2005).
- GLAXO GROUP LTD: WO2005099706 (2005).
- GLAXO GROUP LTD: WO2005112644 (2005).
- GLAXO GROUP LTD: WO2005118594 (2005).